This paper attempts to fit the best survival model distribution for the Malaysian COVID-19 new infections experience of Wave I/II and Wave III using the well-known Survival Data Analysis (SDA) procedures. The purpose of fitting such models is to reduce the complexity and frequency of the COVID-19 new infections data into a single measure of scale and shape parameters to enable monitoring of weekly trends, undertake short term forecasts and estimate duration when the virality will be contained. The analysis showed a Weibull distribution is the best statistical fit for Malaysia’s new infections COVID-19 data. The estimates of scale and shape parameters for Wave I/II was 0.05901 and 2.48956 and for Wave III was 0.06463 and 2.5693, respectively. Much higher hazard force in Wave III is due to weaker control in the implementation of cordon sanitaire measures imposed in containing the virality spread. Based on the survival function the short-term forecasts showed that the number of new infections projected to decline from 23,282 cases in 28th week to 22,017 cases in 31st week. Similarly, based on the cumulative hazard function the duration estimated for containing the virality completely projected to stretch over another 19.6 weeks under the prevailing conditions.
WHO (2020). Coronavirus disease (COVID-19) Weekly Epidemiological Update and WHO (January 2021). Coronavirus disease (COVID-19) advice for the public. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/advice-for-public. This content is last updated on 6 January 2021.
2.
ManikandanS. Frequency distribution. Journal of Pharmacology and Pharmacotherapeutics. 2011; 2(1): 54. doi: 10.4103/0976-500x.77120.
3.
OwenFJonesR. Statistics (2nd ed.). Longman London and New York.
4.
KapurJNSaxenaHC. Mathematical Statistics. Fourth Edition. S. Chand and Company Limited. 1999.
5.
AbdullahJMWan IsmailWFNMohamadIAb RazakAHarunAMusaKILeeYY. A critical appraisal of COVID-19 in Malaysia and beyond. Malaysian Journal of Medical Sciences. 27(2): 1-9. doi: 10.21315/mjms2020.27.2.1.
6.
WagnerAL. What Makes a “Wave” of Disease? An Epidemiologist Explains. The Conversation. Chicago. 2002.
7.
Bernoulli, Daniel. Reflexions sur les avantages de l’inoculation. Mercure de France, June issue, 173-190. Gani J. (1978). Some problems of epidemic theory (with discussion). Journal of the Royal Statistical Society Series A. 1760; 141: 323-347.
8.
BaileyNTJ. The mathematical theory of infectious diseases and its application. London: Griffin: Thom, R. 1975: Structural stability and morphogenesis. Reading, Massachusetts: Benjamin. Progress in Human Geography. 1983; 7(3): 442-444. doi: 10.1177/030913258300700313. 1975.
9.
ThomasRM. Blending Qualitative and Quantitative Research Methods in Theses and Dissertations. Thousand Oaks, CA: Corwin Press. Journal of Mixed Methods Research. 2007; 1(3): 295-297. doi: 10.1177/1558689806294476. 2003.
10.
FuentesMKupermanM. Cellular automata and epidemiological models with spatial dependence. A Statistical and Theoretical Physics. 1999; 267: 471-486. doi: 10.1016/S0378-4371(99)00027-8.
11.
SirakoulisGKarafyllidisIThanailakisA. A cellular automaton model for the effects of population movement and vaccination on epidemic propagation. Ecological Modelling. 2000; 133: 209-223. doi: 10.1016/S0304-3800(00)002945.
12.
BoxGJenkinsG. Time Series Analysis: Forecasting and Control. San Francisco. Holden-Day. 1970.
13.
ChatfieldC. The Analysis of Time Series: An Introduction. Chapman and Hall. CRC Press, Boca Raton. 2004.
14.
LawsonAB, et al. Spatial mixture relative risk models applied to disease mapping. Statistics in Medicine. 2002.
15.
BaileyTCGatrellAC. Interactive spatial data analysis in medical geography. Social Science & Medicine. 1996; 42(Issue 6): 843-855.
16.
BernardinelliLClaytonDPascuttoCMontomoliCGhislandiMSonginiM. Bayesian analysis of space – time variation in disease risk. Statistics in Medicine. 1995; 14(Issue 21-22).
17.
KnorrHeldL, Besag. Modelling risk from a disease in time and space. Statistics in Medicine. 1998; 17: 2045-2046.
18.
ElisaTLOscarTG. Survival analysis in public health research. Annual Review of Public Health. 1997 18; 1: 105-134.
19.
CoxDROakesD. Analysis of Survival Data. Chapman and Hall. London. 1984.
20.
GehanEA. A generalized two-sample Wilcoxon test for doubly-censored data. Biometrika. 1965; 52: 650-53.
21.
GehanEA. A generalized Wilcoxon test for comparing arbitrarily singly-censored samples. Biometrika. 1965; 52: 203-23.
22.
PetoRPetoJ. Asymptotically efficient rank invariant procedures. J. R. Statist. Soc. 1983; A135: 185-207.
23.
FennPMcGuireAPhillipsVBackhouseMJonesD. The analysis of censored-treatment cost data in economic evaluation. Med. Care. 1995; 33: 851-63.
24.
SaekiSOgataHOkuboTTakahashiKHoshuyamaT. Return to work after stroke: A follow-up study. Stroke. 1995; 26: 399-401.
25.
CoxDR. Regression models and life tables. J. R. Statist. Soc. 1972; B34: 187-220.
26.
Salinas-EscuderoGCarrillo-VegaMFGranados-GarcíaV, et al. A survival analysis of COVID-19 in the Mexican population. BMC Public Health. 2020; 20: 1616. doi: 10.1186/s12889-020-09721-2.
27.
Kyeong Hyang Byeona, Dong Wook Kimb, Jaiyong Kimc, Bo Youl Choia, Boyoung Choid, Kyu Dong Chob. Factors affecting the survival of early COVID-19 patients in South Korea: An observational study based on the Korean National Health Insurance Big Data International. Journal of Infectious Diseases. Elsevier. 2021.
28.
AltonenBLArregladoTMLerouxOMurray-RamcharanMEngdahlR. Characteristics, comorbidities and survival analysis of young adults hospitalized with COVID-19 in New York City. PLoS ONE. 2020; 15(12): e0243343. doi: 10.1371/journ.
29.
Eghbal Zandkarimi Ghobad Moradi, Behzad Mohsenpour. The Prognostic Factors Affecting the Survival of Kurdistan Province COVID-19 Patients: A Cross-sectional Study from February to May 2020. International Journal of Health and Policy Management. 2020.
30.
AtlamMTorkeyHEl-FishawyN, et al. Coronavirus disease 2019 (COVID-19): survival analysis using deep learning and Cox regression model. Pattern Anal Application. 2021. doi: 10.1007/s10044-021-00958-0.
31.
Yue Zhao, Deepika Dilip. Survival Analysis of COVID-19 on Democracy with Cox Proportional Hazards Model. Atlas Statistical Research, King of Prussia, PA, United States. Memorial Sloan Kettering Cancer Center, New York, United States. 2020.
32.
Martin Spousta. Parametric analysis of early data on COVID-19 expansion in selected European countries doi: 10.1101/2020.03.31.20049155. 2020.
33.
BuiLVNguyenHTLevineHNguyenHNNguyenT-ANguyenTP, et al. Estimation of the incubation period of COVID-19 in Vietnam. PLoS ONE. 2020; 15(12): e0243889. doi: 10.1371/journal.pone.0243889.
34.
InJLeeS. Statistical data presentation. Korean Journal of Anesthesiology. 70(3): 267. doi: 10.4097/kjae.2017.70.3.267 ISSN 0277-9536.
35.
AndersonTW. The Statistical Analysis of Time Series (1st ed.). Wiley-Interscience.coronavirus-2019/situation-reports. 1994.
36.
RamasamyR. Measuring Information and Knowledge Development in the New Millennium [Master’s thesis].– Research thesis submitted for the award of Master of Philosophy by Multimedia University (MMU), Cyberjaya Multimedia University, Malaysia in 2008.
37.
KleinbaumDGKleinM. Survival Analysis: A Self-Learning Text. (3rd ed.). Springer-Verlag. 2012.
38.
LeeET. Statistical methods for survival data analysis. Lifetime Learning Publications. 1980.
39.
LeeET. Statistical Methods for Survival Data Analysis (Wiley Series in Probability and Statistics) (2nd ed.). Wiley-Interscience. 1992.
40.
LeeETWangJW. Statistical Methods for Survival Data Analysis (Wiley Series in Probability and Statistics) (3rd ed.). Wiley-Blackwell. 2003.
41.
SinhaSK. Reliability and Life Testing. Wiley Eastern Limited. Bombay, India. 1986.
42.
Fernández-Sainz, Ana. An Empirical Investigation of Parametric and Semiparametric Estimation Methods in Sample Selection Models. Journal of Quantitative Methods for Economics and Business Administration. 2010.
43.
ShahAUMSafriSNAThevadasRNoordinNKRahmanAASekawiZIderisASultaMTH. COVID-19 outbreak in Malaysia: Actions taken by the Malaysian government.International Journal of Infectious Diseases. 2020; 97: 108-116. doi: 10.1016/j.ijid.2020.05.093.
44.
RamasamyR. Survival Data Analysis of the Flow of Vital Event Forms in Peninsular Malaysia. [Paper presentation]. Seminar paper submitted as a part of requirements for Post Graduate Course in Population Studies, International Institute of Population Sciences, Deonar, Bombay. 1990.
45.
RobertE. Ricklefs, Alex Scheuerlein, Biological Implications of the Weibull and Gompertz Models of Aging. The Journals of Gerontology: Series A. 1 February 2002; 57(Issue 2): B69-B76. doi: 10.1093/gerona/57.2.B69.
46.
JuckettDRosenbergB. Comparison of the Gompertz and Weibull functions as descriptors for human mortality distributions and their intersections. Mechanisms of Ageing and Development. 1993; 69: 1-31. doi: 10.1016/0047-6374(93)90068-3.
47.
KunduDManglickA. Discriminating between the Weibull and log-normal distributions. 2004. doi: 10.1002/nav.20029.
48.
BalakrishnanN. Handbook of the Logistic Distribution, Marcel Dekker, New York. 1992.
49.
GehanEASiddiquiMM. Simple Regression Methods for Survival Time.
